TABLE OF CONTENTS
|  |  |  | Volume 30, Issue 1 (January 2016) |  | In this issue Reviews Clinical Studies Case Series Correspondence
Also new    AOP | |  |  |  | | Advertisement |  | SUBMIT TO EYE
Submit your research to Eye and enjoy a wide range of benefits, including: - Fast Track Review
- Hosted on nature.com with 9.4 million unique users per month
- Monthly average of 5,000 webpage views and 100,000+ full text article views
- 40,000+ eAlert registrants
Find out how to submit your research today | | | |  |  | Reviews | Top |  | Complement pathway biomarkers and age-related macular degenerationM Gemenetzi and A J Lotery Eye 2016 30: 1-14; advance online publication, October 23, 2015; 10.1038/eye.2015.203 Abstract | Full Text |  |  |  | Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysisH Q Lu, E Q Wang, T Zhang and Y X Chen Eye 2016 30: 15-22; advance online publication, October 30, 2015; 10.1038/eye.2015.208 Abstract | Full Text |  | Clinical Studies | Top |  | Intraoperative optical coherence tomography in macula involving rhegmatogenous retinal detachment repair with pars plana vitrectomy and perfluoron
O Toygar and C D Riemann Eye 2016 30: 23-30; advance online publication, December 11, 2015; 10.1038/eye.2015.230 Abstract | Full Text |  |  |  | Horner’s syndrome in patients admitted to the intensive care unit that have undergone central venous catheterization: a prospective studyZ Butty, J Gopwani, S Mehta and E Margolin Eye 2016 30: 31-33; advance online publication, September 18, 2015; 10.1038/eye.2015.181 Abstract | Full Text |  |  |  | Spectral domain ocular coherence tomography findings pre- and post vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathyI Dooley, H Laviers, E Papavasileiou, C Mckechnie and H Zambarakji Eye 2016 30: 34-39; advance online publication, September 25, 2015; 10.1038/eye.2015.178 Abstract | Full Text |  |  |  | Vision-related quality of life, metamorphopsia, and stereopsis after successful surgery for rhegmatogenous retinal detachmentG Lina, Q Xuemin, W Qinmei and S Lijun Eye 2016 30: 40-45; advance online publication, October 2, 2015; 10.1038/eye.2015.171 Abstract | Full Text |  |  |  | Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapyL Lumbroso-Le Rouic, I Aerts, D Hajage, C Lévy-Gabriel, A Savignoni, N Algret, N Cassoux, A-I Bertozzi, M Esteve, F Doz and L Desjardins Eye 2016 30: 46-52; advance online publication, October 2, 2015; 10.1038/eye.2015.179 Abstract | Full Text |  |  |  | Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucomaR A Mahdy, S M Al-Mosallamy, M A Al-Aswad, A Bor'i and W M El-Haig Eye 2016 30: 53-58; advance online publication, October 2, 2015; 10.1038/eye.2015.182 Abstract | Full Text |  |  |  | Clinical features of intratarsal keratinous cystsJ A Kim, N Kim, H-K Choung, M J Lee, C Lee and S I Khwarg Eye 2016 30: 59-63; advance online publication, October 2, 2015; 10.1038/eye.2015.184 Abstract | Full Text |  |  |  | Chloroquine retinopathy: pattern of presentation in Ibadan, Sub-Sahara AfricaT S Oluleye, Y Babalola and M Ijaduola Eye 2016 30: 64-67; advance online publication, October 2, 2015; 10.1038/eye.2015.185 Abstract | Full Text |  |  |  | The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease OPENJ Taylor, L J Scott, C A Rogers, A Muldrew, D O'Reilly, S Wordsworth, N Mills, R Hogg, M Violato, S P Harding, T Peto, D Townsend, U Chakravarthy and B C Reeves Eye 2016 30: 68-78; advance online publication, October 9, 2015; 10.1038/eye.2015.170 Abstract | Full Text |  |  |  | Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumabT D Papakostas, L Lim, T van Zyl, J B Miller, B S Modjtahedi, C M Andreoli, D Wu, L H Young, I K Kim, D G Vavvas, D D Esmaili, D Husain, D Eliott and L A Kim Eye 2016 30: 79-84; advance online publication, October 9, 2015; 10.1038/eye.2015.175 Abstract | Full Text |  |  |  | Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older childrenS Okumuş, V Öner, C Durucu, E Coşkun, Ü Aksoy, E Durucu, L Şahin and I Erbağcı Eye 2016 30: 85-88; advance online publication, October 9, 2015; 10.1038/eye.2015.189 Abstract | Full Text |  |  |  | Meeting the UK driving vision standards with reduced contrast sensitivityS Rae, K Latham and M F Katsou Eye 2016 30: 89-94; advance online publication, October 16, 2015; 10.1038/eye.2015.188 Abstract | Full Text |  |  |  | Primary posterior continuous curvilinear capsulorhexis combined with diffractive multifocal intraocular lens implantationM Ouchi Eye 2016 30: 95-101; advance online publication, October 23, 2015; 10.1038/eye.2015.201 Abstract | Full Text |  |  |  | Depth evaluation of intended vs actual intacs intrastromal ring segments using optical coherence tomographyR Barbara, A Barbara and M Naftali Eye 2016 30: 102-110; advance online publication, October 23, 2015; 10.1038/eye.2015.202 Abstract | Full Text |  |  |  | Retinal vessel structure measurement using spectral-domain optical coherence tomographyT H Rim, Y S Choi, S S Kim, M-j Kang, J Oh, S Park and S H Byeon Eye 2016 30: 111-119; advance online publication, October 23, 2015; 10.1038/eye.2015.205 Abstract | Full Text |  |  |  | High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmosN Relhan, S Jalali, N Pehre, H L Rao, U Manusani and L Bodduluri Eye 2016 30: 120-126; advance online publication, October 23, 2015; 10.1038/eye.2015.206 Abstract | Full Text |  |  |  | Prolonged organ culture reduces the incidence of endothelial immune reactionsP Maier, S Heinzelmann, D Böhringer and T Reinhard Eye 2016 30: 127-132; advance online publication, October 23, 2015; 10.1038/eye.2015.207 Abstract | Full Text |  |  |  | South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experienceF Ghanchi and C A Hazel Eye 2016 30: 133-138; advance online publication, October 23, 2015; 10.1038/eye.2015.209 Abstract | Full Text |  |  |  | Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study OPENC Bruè, A Pazzaglia, C Mariotti, M Reibaldi and A Giovannini Eye 2016 30: 139-145; advance online publication, October 30, 2015; 10.1038/eye.2015.199 Abstract | Full Text |  |  |  | Ultrastructure of medial rectus muscles in patients with intermittent exotropiaJ Yao, X Wang, H Ren, G Liu and P Lu Eye 2016 30: 146-151; advance online publication, October 30, 2015; 10.1038/eye.2015.213 Abstract | Full Text |  | Case Series | Top |  | Staphylococcal endogenous endophthalmitis in association with pyogenic vertebral osteomyelitisL R Steeples and N P Jones Eye 2016 30: 152-155; advance online publication, October 9, 2015; 10.1038/eye.2015.200 Abstract | Full Text |  |  |  | The ocular phenotype of stiff-skin syndromeS Chamney, B Cartmill, O Earley, V McConnell and C E Willoughby Eye 2016 30: 156-159; advance online publication, October 16, 2015; 10.1038/eye.2015.183 Abstract | Full Text |  |  |  | ‘Shadow sign’ in congenital hypertrophy of the retinal pigment epithelium of young myopic pigmented patientsM Y Chang, J B McBeath, C A McCannel and T A McCannel Eye 2016 30: 160-163; advance online publication, October 16, 2015; 10.1038/eye.2015.187 Abstract | Full Text |  | Correspondence | Top |  | Are junior doctors in today's NHS competent in managing ophthalmic cases in the emergency department?E Y Ah-kee, R A Scott, A Shafi, G McCabe and L T Lim Eye 2016 30: 164; advance online publication, October 9, 2015; 10.1038/eye.2015.193 Full Text |  |  |  | Comment on ‘The accuracy of the Edinburgh Red Eye Diagnostic Algorithm’T N Soomro and J Buchan Eye 2016 30: 164-165; advance online publication, October 16, 2015; 10.1038/eye.2015.192 Full Text |  |  |  | Reply: ‘The accuracy of the Edinburgh Red Eye Diagnostic Algorithm’H Timlin, L Butler and M Wright Eye 2016 30: 165; advance online publication, October 16, 2015; 10.1038/eye.2015.195 Full Text |  |  |  | Comment on ‘Topiramate maculopathy secondary to dose titration: first reported case’P Kozner, S K Wagner, B Brozek and S Althauser Eye 2016 30: 165-166; advance online publication, October 16, 2015; 10.1038/eye.2015.194 Full Text |  |  |  | Response to ‘Comment on Topiramate maculopathy secondary to dose titration: first reported case’R J Symes, P S Severn, R Rajendram and B Pal Eye 2016 30: 166; advance online publication, October 16, 2015; 10.1038/eye.2015.196 Full Text |  |  |  | TLP: a premature conceptA Pircher and H E Killer Eye 2016 30: 166-167; advance online publication, November 13, 2015; 10.1038/eye.2015.223 Full Text |  |  |  | Reply to: ‘TLP: a premature concept’I Januleviciene, L Siaudvytyte, A Daveckaite, A Ragauskas, B Siesky and A Harris Eye 2016 30: 167-168; advance online publication, November 13, 2015; 10.1038/eye.2015.228 Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Eye. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment